Stock speculation is based on the Jin Kirin analyst Research report, authoritative, professional, timely and comprehensive, to help you tap potential theme opportunities.Cryptomario!
Public offering funds are heavily positioned in two major industries.
According to the comparison between the top ten tradable shareholders in the first quarter of listed companies and the positions of public funds in the first quarter, we can get the situation of hidden heavy stocks in the first quarter of public funds.
According to the industry of application level, the market value of invisible holdings of electronics and pharmaceutical biology by public offering funds is more than 60 billion yuan, which is 619 respectively.Cryptomario81 billion yuan and 60.185 billion yuan, the number of related stocks is more than 480; the market value of shares held by power equipment is then 42.91 billion yuan; and the market value of shares held by other sectors such as machinery and equipment, non-bank finance, and computers is more than 20 billion yuan.
In the electronic sector, a large number of semiconductor chip stocks invisible holding market capitalization. Such as China Resources Micro, Tuojing Technology, Shanghai Silicon Industry, Jingchen shares and other shares, the market value of the shares are all more than 2 billion yuan. Most of them are held by ETF funds, but there are exceptions. For example, Nuoan growth mixture managed by Liu Huiying entered the list of the top 10 tradable shareholders of Bauhinia Technology and increased its holdings by 221100 shares compared with the previous period.
Liu Huiying said in the fund's quarterly report that the performance of overseas chip stock prices verified that the upward trend of the global semiconductor business cycle had begun, superimposing the long-term industrial trend of domestic substitution of Chinese chips. The domestic chip sector is expected to form a Davis double-click of performance and valuation after that. The current market position chip plate investment performance price is relatively high, dawn is coming.
Tianfeng Securities also believes that the semiconductor cycle is currently in a relative bottom range. The marginal improvement of semiconductor companies increased sharply in the first quarter compared with the same period last year; benefiting from the semiconductor cycle recovery + AI and other application catalysis, superimposed long-term domestic substitution trend, some semiconductor manufacturers ushered in a high profit increase and are optimistic that the industry will achieve high growth in the second quarter.
As for the pharmaceutical biology sector, fund managers who specialize in this direction have also expressed optimism about the future of the industry. Wan Min, the medical fund manager of the financing fund, said in the A quarterly report of the financing health industry that with the advent of the best part of the new round of aging, under the background of the stabilization of the policy framework and the fading of the transient base effect of the suppressing plate, remain optimistic about the medium-and long-term prospects of the plate, the pharmaceutical sector is expected to usher in a double improvement of fundamentals and policy margin, the plate valuation is expected to be repaired, and there are many segments of the pharmaceutical sector in the trillion market. There is no shortage of structural opportunities.
73 shares have an invisible heavy position of more than 1 billion yuan
In terms of individual stocks, the market value of invisible holdings of 73 shares by public funds exceeds 1 billion yuan. The market value of the shares held by China Construction Corporation and China Shenhua is more than 3 billion yuan, which is 3.31 billion yuan and 3.133 billion yuan respectively. The main shareholders are Castrol Shanghai and Shenzhen 300ETF, Huaxia Shanghai Stock Exchange 50ETF and Yi Fang Da Shanghai Shenzhen 300ETF. Among them, Huaxia Shanghai 50 ETF increased its holdings in China Construction and China Shenhua 95.6596 million shares and 15.0258 million shares respectively in the first quarter.
In addition, Huarun Micro, Tuojing Technology, Wanhua Chemical, Central Control Technology and other stocks have a market capitalization of more than 2.5 billion yuan.
In terms of shareholdings, public funds have invisible holdings of more than 100 million shares in 34 shares. Among them, China Construction, Hefi Optoelectronics-U and Bank of China ranked the top three, with invisible shareholdings of 632 million shares, 517 million shares and 510 million shares respectively; for Tianfeng Securities, China Unicom, Sinopec and China General account, the shareholdings were more than 300 million shares.
Judging from the proportion of invisible shares held by public offering funds to outstanding shares, the proportion of 63 shares is more than 10%. Essen shares ranked first, with a proportion of 33.74%; Shengke Communications-U ranked second with a proportion of 26.26%; and five invisible shares, such as Zhi Te Xincai, Zhixiang Jintai-U, Shengmei Shanghai, Melland and Ecco Optoelectronics, also accounted for more than 20%.
Essen Co., Ltd. is the main supplier of domestic advanced packaging photoresist matching reagent products. The company takes advanced packaging negative photoresist, OLED photoresist and wafer PSPI process photoresist as a breakthrough, photoresist products cover wafer manufacturing, advanced packaging and semiconductor display and other application fields. The company achieved a net profit of 7.5101 million yuan in the first quarter, an increase of 112.28% over the same period last year.
These public offering funds have large hidden positions and large market capitalization.
From the perspective of public offering funds, excluding ETF funds and LOF funds, Glenn's China Europe Healthcare Hybrid An is the fund with the highest market capitalization of invisible holdings, with 10.176 billion yuan. The top pharmaceutical stocks are Kailaiying, Tiantan Biology, Yifeng Pharmacy, Jiuzhou Pharmaceutical, General Strategy Medical (rights protection), which are 1.314 billion yuan, 983 million yuan, 817 million yuan, 742 million yuan and 731 million yuan respectively.
Glenn said that looking forward to the second quarter, it is still optimistic about the innovation-driven pharmaceutical industry chain. The policy continues to strengthen the support for innovation in the field of medicine and biology. As an important part of the new quality productivity, pharmaceutical innovation is also the most firm direction of enterprise layout. 2024 is expected to usher in the peak period of approval and marketing of related innovative drugs.
In addition, the market value of Xingquan Herun mixed invisible shareholdings is 6.024 billion yuan, of which the market value of Gujia household shares is more than 500 million yuan, and the market value of Huitai Medical, Zhejiang Dingli, Juhua shares and Geke Weiwei is more than 400 million yuan. Ruiyuan growth value mixed A, China Merchants Zhong Zheng Liquor Index An invisible heavy position market capitalization of more than 4.5 billion yuan. The former heavy warehouse new Zebang, national porcelain materials more than 400 million yuan; the latter heavy warehouse alcoholic wine, old white dry wine, Shuijingfang, Shunxin agriculture more than 600 million yuan.
